4//SEC Filing
Breedlove Robert Charles 4
Accession 0000950170-25-075870
CIK 0001783183other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 5:17 PM ET
Size
5.4 KB
Accession
0000950170-25-075870
Insider Transaction Report
Form 4
Breedlove Robert Charles
Principal Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-05-19+33,000→ 33,000 totalExercise: $4.39Exp: 2035-05-18→ Common Stock (33,000 underlying)
Footnotes (1)
- [F1]The stock option will vest with respect to 25% of the shares of common stock on May 19, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0002066645
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 5:17 PM ET
- Size
- 5.4 KB